NURIX THERAPEUTICS, INC.Nurix Therapeutics, Inc. • January 28th, 2022 • Pharmaceutical preparations
This employment letter sets forth the terms confirms your continued employment as Chief Financial Officer of Nurix Therapeutics, Inc., a Delaware Corporation (the “Company” or “Nurix”). You will continue to report to the Company’s Chief Executive Officer. This employment letter amends and restates the employment letter entered into between you and Nurix, dated February 20, 2020 (the “Prior Agreement”).
